13:00
THE UCB-EHRLICH AWARD FOR EXCELLENCE IN MEDICINAL CHEMISTRY
Award Ceremony
Dr Yves P. AUBERSON
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Basel, Switzerland
Dr Adrian HALL
UCB PHARMA S.A., Braine-l'Alleud, Belgium
13:10
The UCB-Ehrlich Award for Excellence in Medicinal Chemistry
Award Lecture
Experiences & Future Direction for Medicinal Chemistry in Cardiovascular, Renal and Metabolism Diseases (AL002)
Dr Malin LEMURELL
ASTRAZENECA, Gothenburg, Sweden
Dr. Malin Lemurell is the Head of Head of Medicinal Chemistry in Cardiovascular, Renal and Metabolism at AstraZeneca Gothenburg, Sweden. Since 2013 she has been leading the department with 60+ Medicinal Chemists supporting the portfolio across multiple chemical modalities. Malin received her PhD at the Gothenburg University in 1999 in organic chemistry. After post-doctoral studies on metal catalyzed asymmetric oxidation at The Scripps Research Institute in California with Prof. Barry Sharpless, she joined AstraZeneca as a scientist and has subsequently held various leadership roles. Dr. Lemurell is an author of multiple publications and patents, including patents related to eg. Odevixibat and AZD5718 (Phase II). Her current interests include drug design across small molecules and New Modalities, targeted drug delivery, drugging RNA structure using small molecules and to develop drug hunters of the future.
13:50
THE PROUS INSTITUTE-OVERTON AND MEYER AWARD FOR NEW TECHNOLOGIES IN DRUG DISCOVERY
Award Ceremony
Dr Yves P. AUBERSON
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Basel, Switzerland
Dr Josep Jr. PROUS
PROUS INSTITUTE FOR BIOMEDICAL RESEARCH, Barcelona, Spain
14:00
The Prous Institute - Overton and Meyer Award for New technologies in Drug Discovery
Award Lecture
De Novo Drug Design with Machine Intelligence (AL003)
Prof. Gisbert SCHNEIDER
ETH ZÜRICH, Zürich, Switzerland
14:40
EFMC Fellows Ceremony
Prof. Rui MOREIRA
UNIVERSITY OF LISBON, Lisbon, Portugal
Dr Yves P. AUBERSON
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Basel, Switzerland
15:10
Closing